The global diabetes drugs market is expected to grow at a CAGR of 6.50% during the forecast period of 2019-2027

Friday, October 19, 2018 General News
Email Print This Page Comment bookmark
Font : A-A+

LONDON, Oct. 18, 2018 /PRNewswire/ -- KEY FINDINGSThe growth in the global diabetes drugs market is mainly driven

by increased diabetic population and obesity rates in recent years.The North American market holds the largest share of the global market.Download the full report: https://www.reportbuyer.com/product/5365462 The global diabetes drugs market is
expected to grow at a CAGR of 6.50% during the forecast period of 2019-2027.MARKET INSIGHTSThe important driver for the growth in this market is the increase in the prevalence of diabetes which is because of the increasing obesity among people caused by unhealthy diets and sedentary lifestyles.The diabetes drugs market segments include diabetes type and product class.Diabetes drugs manufacturers offer products for use by both the types (type 1 and type 2) of diabetic patients. Growing elderly population is also influencing the market growth in a big way as the life expectancy rate is rising and the birth rate is declining at the same time.REGIONAL INSIGHTSThe major countries considered in every region are North America (The United States and Canada), Europe (Germany, United Kingdom, France, Italy, and Rest of Europe) and Asia-Pacific (China, India, Japan, South Korea and Rest of Asia Pacific).Rising prevalence of diabetes and obesity rate is anticipated to be the key factors for the growth of the diabetes market.Global vendors are expanding their business by establishing their manufacturing facilities in developing countries. Vendors are focusing on strategic collaborations with domestic distribution partners and suppliers to improve their distribution channels.COMPETITIVE INSIGHTSLeading brands in the global market of diabetes drugs are Eli Lilly And Company, AstraZeneca Plc., B.Braun Melsungen Ag, Novo Nordisk A/S, Sanofi, Diavacs Inc., Xoma Corp., Albireo Pharma Inc., Macrogenics Inc., Astellas Pharma, Glaxosmithkline, Merck, Pfizer and Xeris Pharmaceuticals.Download the full report: https://www.reportbuyer.com/product/5365462 About Reportbuyer Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers For more information: Sarah Smith Research Advisor at Reportbuyer.com Email: sarah@reportbuyer.com Tel: +1 (718) 213 4904 Website: www.reportbuyer.com

Cision View original content:http://www.prnewswire.com/news-releases/the-global-diabetes-drugs-market-is-expected-to-grow-at-a-cagr-of-6-50-during-the-forecast-period-of-2019-2027--300733808.html

SOURCE ReportBuyer



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store